Natsimbio appointed the only blood plasma producer

At the end of January 2022, the Prime Minister Mikhail Mishustin signed an order approving the National Immunobological Company () Natsimbio as the sole executor of plasma processing work blood prepared by FMBA Russia on its own or received from organizations belonging to the blood service, or acquired from these companies. State contracts with the Rostec holding included in the "" will be concluded until the end of 2023.

Natsimbio appointed the only blood plasma producer

Natsimbio will be the executor of the following medicines:

• human immunoglobulin normal;
• albumin;
• human immunoglobulin vs. COVID-19;
• immunoglobulin against tick-borne encephalitis;
• human anti-globulin;
• human anti-staphylococcal immunoglobulin;
• human immunoglobulin against hepatitis B.

As specified in the document published on the official Internet portal of legal information, Natsimbio will be able to order services from subcontractors, but she herself must perform at least 2% of the work on state contracts.

Back in 2018, the Government of the Russian Federation extended Natsimbio's status as the only supplier for 2018-2019, but since 2020 the company has stopped supplying blood products to government agencies. Then it was reported that the blood preparation production site, which Natsimbio pledged to launch when it received the status of the only supplier, was never completed, and Kirov Plasma JSC was liquidated.

By February 2022, Microgen, part of Natsimbio, produces normal human immunoglobulin, immunoglobulin against tick-borne encephalitis, against hepatitis B, and against COVID-19. The latter is included in the recommendations of the Ministry of Health of the Russian Federation on the treatment and diagnosis of a new coronavirus (COVID-19) infection.

At the end of 2021, Natsimbio completed clinical studies of the world's first recorded specific immunoglobulin against coronavirus infection - Covid globulin. It was developed from blood plasma of sick COVID-19 people. Such treatment will be used in the severe course of the disease, when other drugs do not help.^[1]

Notes